Otonomy is a clinical-stage biopharmaceutical company that develops and commercializes therapeutics for ear diseases and disorders in the US and Canada. Its lead product candidate, AuriPro, completed Phase III clinical trials for the treatment of pediatric patients with middle ear effusion or fluid during tympanostomy tube placement surgery.